EMulate Therapeutics 2021 Year in Review - A Pivotal Year for the Company

Feb 1

Written By Kyle Kingma

Kyle Kingma

EMulate Therapeutics Issues White Paper Detailing Magnetic Field Effects Via Low and Ultra-Low Radio Frequency Energy (ulRFE(R))

EMulate Therapeutics Announces the Incorporation of Two Wholly Owned Subsidiaries